Major U.S. Drugstore Chains Pull Zantac Amid Carcinogen Concern

Bookmark
(Bloomberg) -- The three major U.S. pharmacy chains are removing versions of the heartburn drug Zantac from store shelves as health regulators investigate a probable carcinogen detected in the popu...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.